GRAIL, LLC (GRAL : NASDAQ)
Common Stock
$140.58
USD
+7.97 (6.01%)
Last updated: 2026-10-09
Follow GRAL
GRAL
GRAIL, LLC
WealthAwesomePerformance
1 Day
+6.01%
1 Week
-1.87%
1 Month
+81.44%
YTD
+136.47%
Key Statistics
Market Cap
$6.28B
52W High
$166.47
52W Low
$41.50
P/E Ratio
-
50 Day MA
$92.11
200 Day MA
$74.94
Beta
2.84
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/9/2026 | $133.50 | $142.57 | $133.31 | $140.58 | $140.58 | 773,700 |
| 10/8/2026 | $130.00 | $134.56 | $127.46 | $132.61 | $132.61 | 1,311,879 |
| 10/7/2026 | $134.00 | $139.00 | $130.56 | $132.90 | $132.90 | 990,032 |
| 10/6/2026 | $159.43 | $166.47 | $135.80 | $137.28 | $137.28 | 2,023,610 |
| 10/5/2026 | $143.00 | $156.49 | $140.31 | $154.08 | $154.08 | 1,467,657 |
| 10/2/2026 | $135.52 | $143.50 | $134.45 | $143.26 | $143.26 | 873,800 |
| 10/1/2026 | $138.23 | $141.54 | $132.04 | $132.56 | $132.56 | 1,090,157 |
| 9/30/2026 | $138.27 | $151.46 | $136.00 | $140.12 | $140.12 | 1,916,874 |
| 9/29/2026 | $132.75 | $140.88 | $131.20 | $136.57 | $136.57 | 904,383 |
| 9/28/2026 | $128.90 | $134.42 | $126.74 | $132.63 | $132.63 | 1,104,928 |
Analyst Price Targets
Based on 11 analysts covering GRAL · as of Oct 12, 2026
Wall Street analysts forecast GRAL stock price to fall 17.4% over the next 12 months.
Consensus
Buy3.91 / 5.00
Avg. Target
US$116.10
-17.4% Upside
Current Price
US$140.58
Last close
Analyst Breakdown (11 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GRAL's historical volatility
30-Day Vol
109.3%
Annualized
90-Day Vol
89.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$168.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$149.20 | US$102.33 – US$217.54 |
| 60 trading days | US$158.35 | US$92.90 – US$269.91 |
| 90 trading days | US$168.06 | US$87.47 – US$322.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Financials
- Revenue (TTM)
- $165.26M
- EBITDA
- $-378.49M
- Profit Margin
- -236.95%
- ROE (TTM)
- -16.12%
- EPS (Diluted)
- -9.70
- Book Value
- 56.93
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About GRAL.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DFLI | Dragonfly Energy Holdings Corp. | $3.72 | +658.88% |
| WFF | WF Holding Limited Ordinary Shares | $12.29 | +499.51% |
| ILLR | Triller Group Inc. Common Stock | $0.08 | +100.97% |
| JZ | Jianzhi Education Technology Group Company Limited American Depositary Shares | $1.28 | +53.48% |
| ZYBT | Zhengye Biotechnology Holding Limited Ordinary Shares | $1.73 | +50.45% |
| VEEA | Veea Inc. | $5.70 | +47.29% |
| QETA | Quetta Acquisition Corporation Common Stock | $16.41 | +41.47% |
| PDSB | PDS Biotechnology Corp | $1.38 | +35.29% |
GRAL.US news timeline
4 articles covering GRAL.US, most recent first
Latest